Published October 1982 | Version v1
Journal article

Progress in radiopharmacy of /sup 99m/Tc-compounds

  • 1. Zentralinstitut fuer Kernforschung, Rossendorf bei Dresden (German Democratic Republic)
  • 2. Medizinische Akademie, Dresden (German Democratic Republic). Nuklearmedizinische Klinik

Description

A brief review on the history, current state and design of /sup 99m/Tc-radiopharmaceuticals is given. The short-lived /sup 99m/Tc (physical half-life 6 hours, ideal radiation characteristics) is the most outstanding radionuclide used in nuclear medicine diagnostics. More than 50% of all in vivo examinations are performed with /sup 99m/Tc. The increasing use of /sup 99m/Tc has been tied in with the achievements attained in chemistry and the radiopharmacology of /sup 99m/Tc-compounds and with the introduction of kits for ready-to-use preparations. (author)

Additional details

Additional titles

Original title (German)
Die Entwicklung der Radiopharmazie von Tc-99m-Verbindungen

Publishing Information

Journal Title
Dtsch. Gesundheitsw.
Journal Volume
37
Journal Issue
41
Series
Dtsch. Gesundheitsw.
Journal Page Range
1753-1755
ISSN
0012-0219